...
首页> 外文期刊>Applied Microbiology and Biotechnology >Microbiological synthesis of stereoisomeric 7(/)-hydroxytestololactones and 7(/)-hydroxytestolactones
【24h】

Microbiological synthesis of stereoisomeric 7(/)-hydroxytestololactones and 7(/)-hydroxytestolactones

机译:立体异构7(/) - 羟基唑啉酮和7(/) - 羟基滴答酮的微生物合成

获取原文
获取原文并翻译 | 示例

摘要

Microbiological synthesis of 7- and 7-hydroxy derivatives of testololactone and testolactone was developed based on bioconversion of dehydroepiandrosterone (DHEA) by fungus of Isaria fumosorosea VKM F-881 with subsequent modification of the obtained stereoisomers by actinobacteria. The first stage included obtaining of the stereoisomers of 3,7(/)-dihydroxy-17a-oxa-D-homo-androst-5-en-17-ones in the preparative amounts. Then the conversion of 7-hydroxylated D-lactones obtained by selected actinobacteria of Nocardioides simplex VKM Ac-2033D, Saccharopolyspora hirsuta VKM Ac-666, and Streptomyces parvulus MTOC Ac-21v was studied. Under the transformation of 3,7-dihydroxy-17a-oxa-D-homo-androst-5-en-17-one and its corresponding 7-stereoisomer by N. simplex VKM Ac-2033D and S. hirsuta VKM Ac-666 the 7- and 7-hydroxy-17a-oxa-D-homo-androst-4-ene-3,17-dione (7- and 7-hydroxytestololactone), 7- and 7-hydroxy-17a-oxa-D-homo-androsta-1,4-diene-3,17-dione (7- and 7-hydroxytestolactone) were obtained with molar yields in a range of 60.3-90.9 mol%. The crystalline products of 7-hydroxytestololactone, 7-hydroxytestolactone, and their corresponding 7-hydroxy stereoisomers were isolated, and their structures were confirmed by mass spectrometry and H-1-NMR spectroscopy analyses. The strain of Str. parvulus MTOC Ac-21v transformed 3,7(/)-dihydroxy-17a-oxa-D-homo-androst-5-en-17-ones into the corresponding 3-keto-4-ene analogs and did not show 3-ketosteroid 1(2)-dehydrogenase activity. The activity of actinobacteria towards steroid D-lactones was hitherto unreported.The results contribute to the knowledge of metabolic versatility of actinobacteria capable of transforming steroid substrates and may be applied in the synthesis of potential aromatase inhibitors.
机译:基于Isaria Fumosorosea VKM F-881的真菌的脱氢贫康松(DHEA)的生物转化,开发了睾丸烯酮和睾酮7-羟基衍生物的微生物合成,随后通过actinobacters改变所获得的立体异构体。第一阶段包括在制备量中获得3,7(/) - 二羟基-17A-OXA-D-HONO-ANDROST-5-ZH-17-17的立体异构体。然后研究了通过选定的Nocardioide Simplex VKM AC-2033D,SaccharopolysporaHIRsuta VKM AC-666获得的7-羟基化D-乳酰胺的转化率,SaccharopopysporaHIRsuta VKM AC-666和Streptomyces prustomyces parvulus MTOC AC-21V。在3,7-二羟基-17a-oxa-d-homo-androst-5-en-17-1的转化下,其对应的7立体异构体N.Wimplex VKM AC-2033D和S.Hirsuta VKM AC-666 7-羟基-17A-OXA-D-HONO-ANDROST-4-ENE-3,17-二酮(7-羟基唑酮),7-羟基-17A-OXA-D-Homo-在60.3-90.9mol%的范围内获得钠甾rosta-1,4-二烯-3,17-二酮(7-羟基羟酮)。分离出7-羟基羟基酮,7-羟基羟酮和它们对应的7-羟基立体异构体的结晶产物,并通过质谱法和H-1-NMR光谱分析证实它们的结构。 str的菌株。将Prululus MTOC AC-21V转化为3,7(/) - 二羟基-17a-Oxa-d-Homo-Androst-5-en-17- in相应的3-keto-4-eNE类似物,并没有显示3-酮类opid 1(2 )--丁二糖酶活性。迄今为止,对类固醇D-内酯的抗菌杆菌的活性是未报告的。结果有助于了能够转化类固醇底物的抗菌菌的代谢多功能性的知识,并且可以应用于潜在的芳香酶抑制剂的合成中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号